Marco Polo Marine Ltd. (SGX:5LY)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	221	206	199	131	92	46
Market Cap Growth	-20.00%	3.77%	51.78%	43.11%	100.00%	-23.48%
Enterprise Value	226	181	163	115	83	31
Last Close Price	0.06	0.05	0.05	0.04	0.03	0.01
PE Ratio	10.39	9.51	8.81	6.14	6.20	-
Forward PE	7.68	5.80	5.80	5.80	5.80	5.80
PS Ratio	1.93	1.67	1.57	1.52	1.99	1.48
PB Ratio	1.06	1.03	1.08	0.86	0.80	0.46
P/TBV Ratio	1.14	1.12	1.19	0.94	0.80	0.46
P/FCF Ratio	-	-	-	5.45	12.17	-
P/OCF Ratio	5.36	5.48	7.08	4.57	10.38	11.28
PEG Ratio	0.35	0.51	0.51	0.51	0.51	0.51
EV/Sales Ratio	1.97	1.46	1.28	1.33	1.80	1.01
EV/EBITDA Ratio	7.15	5.65	4.42	6.34	11.41	-
EV/EBIT Ratio	11.00	7.90	5.87	10.69	52.40	-
EV/FCF Ratio	-6.87	-	-	4.76	11.04	-
Debt / Equity Ratio	0.17	0.20	0.05	0.03	0.04	0.01
Debt / EBITDA Ratio	1.10	1.19	0.22	0.20	0.59	-
Debt / FCF Ratio	-	-	-	0.16	0.59	-
Asset Turnover	0.44	0.49	0.61	0.53	0.37	0.26
Inventory Turnover	11.26	12.47	16.28	40.71	31.69	23.76
Quick Ratio	1.46	1.63	2.49	2.37	2.13	2.13
Current Ratio	1.50	1.96	3.32	2.61	3.67	2.50
Return on Equity (ROE)	10.51%	12.42%	15.37%	16.53%	13.77%	-8.84%
Return on Assets (ROA)	4.85%	5.68%	8.32%	4.09%	0.78%	-3.75%
Return on Capital (ROIC)	5.75%	6.60%	9.98%	4.88%	0.90%	-4.26%
Return on Capital Employed (ROCE)	9.00%	10.50%	14.40%	6.80%	1.30%	-
Earnings Yield	9.63%	10.51%	11.35%	16.28%	16.13%	-20.12%
FCF Yield	-14.88%	-11.71%	-2.15%	18.36%	8.22%	-4.44%
Dividend Yield	1.69%	1.85%	1.96%	-	-	-
Payout Ratio	17.60%	17.29%	-	-	-	-
Buyback Yield / Dilution	1.56%	-1.91%	-4.28%	-0.15%	-0.14%	-0.04%
Total Shareholder Return	3.25%	-0.06%	-2.33%	-0.15%	-0.14%	-0.04%

Updated Jan 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.